• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食中晚期糖基化终产物通过破坏肠道微生物组和免疫稳态引发毒理学效应。

Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis.

机构信息

Department of Biomedical Sciences, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

出版信息

J Immunotoxicol. 2021 Jul 24;18(1):93-104. doi: 10.1080/1547691X.2021.1959677.

DOI:10.1080/1547691X.2021.1959677
PMID:34436982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9885815/
Abstract

The aging immune system is characterized by a low-grade chronic systemic inflammatory state ("inflammaging") marked by elevated serum levels of inflammatory molecules such as interleukin (IL)-6 and C-reactive protein (CRP). These inflammatory markers were also reported to be strong predictors for the development/severity of Type 2 diabetes, obesity, and COVID-19. The levels of these markers have been positively associated with those of advanced glycation end-products (AGEs) generated via non-enzymatic glycation and oxidation of proteins and lipids during normal aging and metabolism. Based on the above observations, it is clinically important to elucidate how dietary AGEs modulate inflammation and might thus increase the risk for aging-exacerbated diseases. The present narrative review discusses the potential pro-inflammatory properties of dietary AGEs with a focus on the inflammatory mediators CRP, IL-6 and ferritin, and their relations to aging in general and Type 2 diabetes in particular. In addition, underlying mechanisms - including those related to gut microbiota and the receptors for AGEs, and the roles AGEs might play in affecting physiologies of the healthy elderly, obese individuals, and diabetics are discussed in regard to any greater susceptibility to COVID-19.

摘要

衰老的免疫系统的特征是低度慢性系统性炎症状态(“炎症衰老”),其特征是炎症分子(如白细胞介素 (IL)-6 和 C 反应蛋白 (CRP))的血清水平升高。这些炎症标志物也被报道是 2 型糖尿病、肥胖和 COVID-19 发展/严重程度的强有力预测指标。这些标志物的水平与在正常衰老和代谢过程中通过非酶糖基化和蛋白质及脂质氧化产生的晚期糖基化终产物 (AGEs) 的水平呈正相关。基于上述观察结果,阐明膳食 AGEs 如何调节炎症,从而增加因衰老而加剧的疾病的风险,在临床上非常重要。本综述讨论了膳食 AGEs 的潜在促炎特性,重点讨论了炎症介质 CRP、IL-6 和铁蛋白,以及它们与衰老、特别是 2 型糖尿病的关系。此外,还讨论了潜在的机制——包括与肠道微生物群和 AGEs 的受体有关的机制,以及 AGEs 在影响健康老年人、肥胖者和糖尿病患者的生理方面可能发挥的作用,以及它们对 COVID-19 的易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/d0d254a79d33/nihms-1865814-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/3633c7eb0eb3/nihms-1865814-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/c6fc2ac70cf4/nihms-1865814-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/8eb3007fc633/nihms-1865814-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/d0d254a79d33/nihms-1865814-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/3633c7eb0eb3/nihms-1865814-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/c6fc2ac70cf4/nihms-1865814-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/8eb3007fc633/nihms-1865814-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6a/9885815/d0d254a79d33/nihms-1865814-f0004.jpg

相似文献

1
Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis.饮食中晚期糖基化终产物通过破坏肠道微生物组和免疫稳态引发毒理学效应。
J Immunotoxicol. 2021 Jul 24;18(1):93-104. doi: 10.1080/1547691X.2021.1959677.
2
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis.晚期糖基化终产物(AGEs)及其受体 RAGE 可调节与年龄相关的 COVID-19 发病率和死亡率。综述与假说。
Int Immunopharmacol. 2021 Sep;98:107806. doi: 10.1016/j.intimp.2021.107806. Epub 2021 May 24.
3
Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation.外源性膳食晚期糖基化终产物对微生物群与代谢炎症相互作用机制的影响。
Nutrients. 2020 Aug 19;12(9):2497. doi: 10.3390/nu12092497.
4
Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease.实验动物研究支持饮食中晚期糖基化终产物在健康和疾病中的作用。
Nutrients. 2021 Sep 29;13(10):3467. doi: 10.3390/nu13103467.
5
The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction.膳食晚期糖基化终产物在代谢功能障碍中的作用。
Mol Nutr Food Res. 2021 Jan;65(1):e1900934. doi: 10.1002/mnfr.201900934. Epub 2020 Apr 20.
6
Blood and Tissue Advanced Glycation End Products as Determinants of Cardiometabolic Disorders Focusing on Human Studies.血液和组织中晚期糖基化终产物作为代谢综合征相关心血管疾病的决定因素:基于人体研究。
Nutrients. 2023 Apr 21;15(8):2002. doi: 10.3390/nu15082002.
7
Effect of advanced glycation end product intake on inflammation and aging: a systematic review.晚期糖基化终产物摄入对炎症和衰老的影响:系统评价。
Nutr Rev. 2014 Oct;72(10):638-50. doi: 10.1111/nure.12141. Epub 2014 Sep 17.
8
Comparison of metabolic fate, target organs, and microbiota interactions of free and bound dietary advanced glycation end products.比较游离和结合膳食晚期糖基化终产物的代谢途径、靶器官和微生物组相互作用。
Crit Rev Food Sci Nutr. 2023;63(19):3612-3633. doi: 10.1080/10408398.2021.1991265. Epub 2021 Oct 26.
9
Effect of Advanced Glycation End-Products and Excessive Calorie Intake on Diet-Induced Chronic Low-Grade Inflammation Biomarkers in Murine Models.晚期糖基化终产物和过量热量摄入对小鼠模型饮食诱导的慢性低度炎症生物标志物的影响。
Nutrients. 2021 Sep 2;13(9):3091. doi: 10.3390/nu13093091.
10
Effect of advanced glycation end-products in a wide range of medical problems including COVID-19.晚期糖基化终产物在包括新冠肺炎在内的一系列医学问题中的作用。
Adv Med Sci. 2024 Mar;69(1):36-50. doi: 10.1016/j.advms.2024.01.003. Epub 2024 Feb 8.

引用本文的文献

1
Calycosin and kidney health: a molecular perspective on its protective mechanisms.刺芒柄花素与肾脏健康:对其保护机制的分子视角
Pharmacol Rep. 2025 Jun;77(3):658-669. doi: 10.1007/s43440-025-00728-3. Epub 2025 Apr 18.
2
A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies.代谢功能障碍相关脂肪性肝病综合评述:聚焦甲基乙二醛的发病机制及平衡治疗策略
Int J Mol Sci. 2025 Mar 7;26(6):2394. doi: 10.3390/ijms26062394.
3
Fructose-mediated AGE-RAGE axis: approaches for mild modulation.果糖介导的晚期糖基化终产物-晚期糖基化终产物受体轴:轻度调节方法。
Front Nutr. 2024 Dec 4;11:1500375. doi: 10.3389/fnut.2024.1500375. eCollection 2024.
4
Disproportionately higher cardiovascular disease risk and incidence with high fructose corn syrup sweetened beverage intake among black young adults-the CARDIA study.黑人年轻成年人中,高果糖玉米糖浆甜味饮料摄入与心血管疾病风险和发病率不成比例升高——CARDIA 研究。
Nutr J. 2024 Jul 29;23(1):84. doi: 10.1186/s12937-024-00978-6.
5
Liquid Chromatography with Tandem Mass Spectrometry Analysis of Carboxymethyl Lysine in Indonesian Foods.液相色谱-串联质谱法分析印度尼西亚食品中的羧甲基赖氨酸。
Molecules. 2024 Mar 15;29(6):1304. doi: 10.3390/molecules29061304.
6
Gut Microbiome Dysbiosis as a Potential Risk Factor for Idiopathic Toe-Walking in Children: A Review.肠道微生物失调作为儿童特发性踮脚行走的潜在风险因素:综述。
Int J Mol Sci. 2023 Aug 25;24(17):13204. doi: 10.3390/ijms241713204.
7
Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.晚期糖基化终末产物:糖尿病心血管并发症的关键介质和治疗靶点。
World J Diabetes. 2023 Aug 15;14(8):1146-1162. doi: 10.4239/wjd.v14.i8.1146.
8
Food allergy prevention: Where are we in 2023?食物过敏预防:2023年我们处于什么阶段?
Asia Pac Allergy. 2023 Mar;13(1):15-27. doi: 10.5415/apallergy.0000000000000001. Epub 2023 Apr 28.
9
A Role for Advanced Glycation End Products in Molecular Ageing.晚期糖基化终产物在分子衰老中的作用。
Int J Mol Sci. 2023 Jun 8;24(12):9881. doi: 10.3390/ijms24129881.
10
Do advanced glycation end products contribute to food allergy?晚期糖基化终产物是否会导致食物过敏?
Front Allergy. 2023 Apr 4;4:1148181. doi: 10.3389/falgy.2023.1148181. eCollection 2023.

本文引用的文献

1
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality.可溶性晚期糖基化终末产物受体(sRAGE)作为新冠病毒疾病严重程度的生物标志物以及机械通气需求、急性呼吸窘迫综合征和死亡率的指标。
Ann Intensive Care. 2021 Mar 22;11(1):50. doi: 10.1186/s13613-021-00836-2.
2
Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers.晚期糖基化终产物可溶性受体及其在合并或不合并糖尿病的COVID-19患者中的形式:关于其作为疾病生物标志物作用的初步研究
J Clin Med. 2020 Nov 23;9(11):3785. doi: 10.3390/jcm9113785.
3
SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.SARS-CoV-2 与急诊科、ACE2 和 RAGE 的可能关联:关注易感因素。
FASEB J. 2020 Nov;34(11):14103-14119. doi: 10.1096/fj.202001394RR. Epub 2020 Sep 23.
4
COVID-19 and Diabetes: The Importance of Controlling RAGE.2019冠状病毒病与糖尿病:控制晚期糖基化终末产物受体的重要性
Front Endocrinol (Lausanne). 2020 Jul 14;11:526. doi: 10.3389/fendo.2020.00526. eCollection 2020.
5
RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?RAGE受体:可能是新冠病毒感染的潜在炎症介质?
Med Hypotheses. 2020 Nov;144:109950. doi: 10.1016/j.mehy.2020.109950. Epub 2020 Jun 5.
6
Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.衰老和呼吸道病毒感染免疫反应的作用:对 COVID-19 的潜在影响。
J Immunol. 2020 Jul 15;205(2):313-320. doi: 10.4049/jimmunol.2000380. Epub 2020 Jun 3.
7
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
8
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?细胞外 HMGB1:严重肺部炎症(包括 COVID-19)的治疗靶点?
Mol Med. 2020 May 7;26(1):42. doi: 10.1186/s10020-020-00172-4.
9
SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?严重急性呼吸综合征冠状病毒2介导的肺部炎症反应:我们应该关注晚期糖基化终末产物受体吗?
Inflamm Res. 2020 Jul;69(7):641-643. doi: 10.1007/s00011-020-01353-x. Epub 2020 May 5.
10
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models.晚期糖基化终末产物受体(RAGE)以及糖尿病和心血管疾病中的机制与治疗机遇:来自人类受试者和动物模型的见解
Front Cardiovasc Med. 2020 Mar 10;7:37. doi: 10.3389/fcvm.2020.00037. eCollection 2020.